SK Chemicals Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seongnam Korea, Republic of (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
2004
NCT00351065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

SK Chemicals Co., Ltd. | SK Chemicals Co.,Ltd. | SK Chemicals Investigational Site

Active Ingredients

Drugs in Phase 4 Trials (5)

benserazide (1 trial)

clopidogrel (plavix) (1 trial)

nafamostat (ronastat) (2 trials)

opicapone (Ongentys) (1 trial)

phenylpropanolamine (Propadrine) (4 trials)

Drugs in Phase 3 Trials (18)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

amlodipine (norvasc) (1 trial)

cilostazol (pletal) (3 trials)

docetaxel (taxotere) (1 trial)

febuxostat (uloric) (2 trials)

frovatriptan (frova) (1 trial)

heparin (liquaemin) (1 trial)

hepatitis b immune globulin (human) (BayHep B) (1 trial)

inactivated influenza vaccine (8 trials)

levamlodipine (Conjupri) (1 trial)

live attenuated varicella vaccine (Varivax) (5 trials)

Mirodenafil (7 trials)

pilocarpine (ocusert) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (3 trials)

pulsatilla (2 trials)

sotb07 (2 trials)

tolterodine (detrol) (1 trial)

winfuran (2 trials)

Drugs in Phase 2 Trials (6)

montelukast (singulair) (1 trial)

relenopride (1 trial)

ski3246 (1 trial)

sk-ms10 (1 trial)

sodium chloride (1 trial)

vi-dt typhoid conjugate vaccine (1 trial)

Drugs in Phase 1 Trials (8)

antithrombin iii (human) (thrombate iii) (1 trial)

dapagliflozin (farxiga) (2 trials)

dapoxetine (priligy) (2 trials)

mvix (3 trials)

sitagliptin (januvia) (1 trial)

ski2670 (1 trial)

topiramate (topamax) (1 trial)

yinhsing (1 trial)

Drugs in Other Trials (7)

bismuth (1 trial)

celecoxib (celebrex) (1 trial)

clarithromycin (biaxin) (1 trial)

metronidazole (flagyl) (1 trial)

pantoprazole (protonix) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

tetracycline (tetrex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 4)

Alzheimer Disease (Phase 3)

Arterial Occlusive Diseases (Phase 1)

Asthma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Chickenpox (Phase 3)

Constipation (Phase 2)

Diabetes Mellitus (Phase 3)

Endometriosis (Phase 1)

Erectile Dysfunction (Phase 3)

Gastritis (Phase 2)

Gout (Phase 3)

Hepatitis B (Phase 3)

Herpes Zoster (Phase 3)

Hypertension (Phase 3)

Influenza, Human (Phase 3)

Irritable Bowel Syndrome (Phase 2)

Kidney Diseases (Phase 1)

Kidney Failure, Chronic (Phase 1)

Lung Neoplasms (Phase 3)

Migraine Disorders (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Pneumococcal Infections (Phase 3)

Pruritus (Phase 3)

Renal Insufficiency (Phase 1)

Syndrome (Phase 2)

Typhoid Fever (Phase 2)

Urinary Bladder, Overactive (Phase 3)

Urologic Diseases (Phase 1)

Vestibular Neuronitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 57
  • # of Trial APIs: 44